NDC Product
Human Prescription DrugHumira NDC 50090-4487
- Generic Name
- Adalimumab
- Dosage Form
- Kit
- Route
- N/A
- Marketing
- BLA
Active Listing
ADALIMUMAB
UNII FYS6T7F842
Substance Identification & Data
This profile provides standardized clinical and technical data for Adalimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FYS6T7F842.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 331731-18-1 and the RxNorm Concept ID (RxCUI) 327361. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
ADALIMUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
FYS6T7F842
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
7860
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
NN-74
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Adalimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
ADALIMUMAB
ADALIMUMAB BETA
ADALIMUMAB-AACF
ADALIMUMAB-AATY
ADALIMUMAB-ADAZ
ADALIMUMAB-ADBM
ADALIMUMAB-AFZB
ADALIMUMAB-AQVH
ADALIMUMAB-ATTO
ADALIMUMAB-BWWD
ADALIMUMAB-FKJP
ADALIMUMAB-RYVK
Common Names & Synonyms
ADALIMUMAB (ABBVIE)
ADALIMUMAB (GENETICAL RECOMBINATION)
ADALIMUMAB (GENETICAL RECOMBINATION) [JAN]
ADALIMUMAB (HUMIRA)
ADALIMUMAB [EMA EPAR]
ADALIMUMAB [HSDB]
ADALIMUMAB [INN]
ADALIMUMAB [JAN]
ADALIMUMAB [MART.]
ADALIMUMAB [MI]
ADALIMUMAB [PURPLE BOOK CDER]
ADALIMUMAB [USAN]
ADALIMUMAB [VANDF]
ADALIMUMAB [WHO-DD]
ADALIMUMAB AACF [WHO-DD]
ADALIMUMAB AATY [WHO-DD]
ADALIMUMAB ADAZ [WHO-DD]
ADALIMUMAB ADBM [WHO-DD]
ADALIMUMAB AFZB [WHO-DD]
ADALIMUMAB AQVH [WHO-DD]
ADALIMUMAB ATTO [WHO-DD]
ADALIMUMAB BETA [INN]
ADALIMUMAB BIOSIMILAR (ALVOTECH)
ADALIMUMAB BIOSIMILAR (AMGEN)
ADALIMUMAB BIOSIMILAR (AVT02)
ADALIMUMAB BIOSIMILAR (BOEHRINGER INGELHEIM)
ADALIMUMAB BIOSIMILAR (CELLTRION)
ADALIMUMAB BIOSIMILAR (COHERUS BIOSCIENCES)
ADALIMUMAB BIOSIMILAR (CT-P17)
ADALIMUMAB BIOSIMILAR (FUJIFILM KYOWA KIRIN BIOLOGICS)
ADALIMUMAB BIOSIMILAR (MSB11022)
ADALIMUMAB BIOSIMILAR (MYLAN)
ADALIMUMAB BIOSIMILAR (PF-06410293)
ADALIMUMAB BIOSIMILAR (PFIZER)
ADALIMUMAB BIOSIMILAR (SAMSUNG BIOEPIS)
ADALIMUMAB BIOSIMILAR (SANDOZ)
ADALIMUMAB BIOSIMILAR (YUSIMRY)
ADALIMUMAB BIOSIMILAR (ZRC-3197)
ADALIMUMAB BWWD [WHO-DD]
ADALIMUMAB FKJP [WHO-DD]
ADALIMUMAB RYVK [WHO-DD]
ADALIMUMAB, LICENSE HOLDER UNSPECIFIED
ADALIMUMAB-ADAZ [PURPLE BOOK CDER]
ADALIMUMAB-ADBM [PURPLE BOOK CDER]
ADALIMUMAB-ATTO [PURPLE BOOK CDER]
BCD-057
BI 695501 [WHO-DD]
CHS-1420
CT P17 [WHO-DD]
CYLTEZO
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR) (HUMAN MONOCLONAL D2E7 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL D2E7 LIGHT CHAIN, DIMER
LBAL
M-923
ONS-3010
Brand / Trade Names
ABRILADA
AMJEVITA
AMSPARITY
EXEMPTIA
HADLIMA
HULIO
HUMIRA
HYRIMOZ
IDACIO
SIMLANDI
TRUDEXA
YUFLYMA
YUSIMRY
Technical Codes
ABP-501
ADALIMUMAB BIOSIMILAR (FKB-327)
AVT02
AVT-02
BI695501
BI-695501
CTP17
CT-P17
D2E7
D3E7
FKB-327
GP2017
GP-2017
LU200134
LU-200134
M923
MSB11022
MSB-11022
PF-06410293
SB5
SB-5
ZRC3197
ZRC-3197
NDC Products Containing ADALIMUMAB
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
